These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 34958732)

  • 1. Utilization of Digoxin among Hospitalized Older Patients with Heart Failure and Atrial Fibrillation in Thailand: Prevalence, Associated Factors, and Clinical Outcomes.
    Singkham N; Wongsalap Y; Poolpun D; Phetnoo S; Somkhon C
    Ann Geriatr Med Res; 2021 Dec; 25(4):260-268. PubMed ID: 34958732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of Digoxin on Mortality in Patients With Atrial Fibrillation Stratified by Heart Failure: Findings From Gulf Survey of Atrial Fibrillation Events in the Middle East.
    Al-Zakwani I; Panduranga P; Zubaid M; Sulaiman K; Rashed WA; Alsheikh-Ali AA; AlMahmeed W; Shehab A; Al Qudaimi A; Asaad N; Amin H
    J Cardiovasc Pharmacol Ther; 2016 May; 21(3):273-9. PubMed ID: 26341119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and predictors of digoxin utilization among heart failure patients with reduced ejection fraction in Qatar.
    Rahhal AA; Awaisu A; Tawengi KM; AbuYousef S; Mekideche L
    Int J Clin Pharm; 2017 Oct; 39(5):1070-1083. PubMed ID: 28823072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mortality in heart failure with atrial fibrillation: Role of digoxin and diuretics.
    Gonzalez-Loyola F; Abellana R; Verdú-Rotellar JM; Bustamante Rangel A; Clua-Espuny JL; Muñoz MA
    Eur J Clin Invest; 2018 Nov; 48(11):e13014. PubMed ID: 30091171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Digoxin and clinical outcomes in systolic heart failure patients on contemporary background heart failure therapy.
    Dhaliwal AS; Bredikis A; Habib G; Carabello BA; Ramasubbu K; Bozkurt B
    Am J Cardiol; 2008 Nov; 102(10):1356-60. PubMed ID: 18993155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relation of digoxin use in atrial fibrillation and the risk of all-cause mortality in patients ≥65 years of age with versus without heart failure.
    Shah M; Avgil Tsadok M; Jackevicius CA; Essebag V; Behlouli H; Pilote L
    Am J Cardiol; 2014 Aug; 114(3):401-6. PubMed ID: 24950677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Digoxin Use to Control Ventricular Rate in Patients with Atrial Fibrillation and Heart Failure Is Not Associated with Increased Mortality.
    Chamaria S; Desai AM; Reddy PC; Olshansky B; Dominic P
    Cardiol Res Pract; 2015; 2015():314041. PubMed ID: 26788401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mineralocorticoid receptor antagonists and cardiovascular mortality in patients with atrial fibrillation and left ventricular dysfunction: insights from the Atrial Fibrillation and Congestive Heart Failure Trial.
    O'Meara E; Khairy P; Blanchet MC; de Denus S; Pedersen OD; Levesque S; Talajic M; Ducharme A; White M; Racine N; Rouleau JL; Tardif JC; Roy D;
    Circ Heart Fail; 2012 Sep; 5(5):586-93. PubMed ID: 22798522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Digoxin use in patients with atrial fibrillation and adverse cardiovascular outcomes: a retrospective analysis of the Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF).
    Washam JB; Stevens SR; Lokhnygina Y; Halperin JL; Breithardt G; Singer DE; Mahaffey KW; Hankey GJ; Berkowitz SD; Nessel CC; Fox KA; Califf RM; Piccini JP; Patel MR;
    Lancet; 2015 Jun; 385(9985):2363-70. PubMed ID: 25749644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased mortality among patients taking digoxin--analysis from the AFFIRM study.
    Whitbeck MG; Charnigo RJ; Khairy P; Ziada K; Bailey AL; Zegarra MM; Shah J; Morales G; Macaulay T; Sorrell VL; Campbell CL; Gurley J; Anaya P; Nasr H; Bai R; Di Biase L; Booth DC; Jondeau G; Natale A; Roy D; Smyth S; Moliterno DJ; Elayi CS
    Eur Heart J; 2013 May; 34(20):1481-8. PubMed ID: 23186806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association Between Digoxin Use and Adverse Outcomes Among Patients in the Chinese Atrial Fibrillation Registry.
    Gao Y; Chang S; Du X; Dong J; Xu X; Zhou Y; Lip GYH; Ma C
    Am J Cardiovasc Drugs; 2019 Dec; 19(6):579-587. PubMed ID: 31077081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Association between duration of digoxin use and adverse outcomes among Chinese patients with atrial fibrillation].
    Chang SS; Gao Y; Xia SJ; Du X; Dong JZ; Ma CS
    Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Sep; 48(9):728-734. PubMed ID: 32957754
    [No Abstract]   [Full Text] [Related]  

  • 13. Temporal Trends of Digoxin Use in Patients Hospitalized With Heart Failure: Analysis From the American Heart Association Get With The Guidelines-Heart Failure Registry.
    Patel N; Ju C; Macon C; Thadani U; Schulte PJ; Hernandez AF; Bhatt DL; Butler J; Yancy CW; Fonarow GC
    JACC Heart Fail; 2016 May; 4(5):348-56. PubMed ID: 26874392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of digoxin on risk of death in heart failure patients treated with b-blockers. Results from Polish part of ESC Heart Failure Long-Term Registry.
    Migaj J; Kałużna-Oleksy M; Nessler J; Opolski G; Crespo-Leiro MG; Maggioni AP; Grajek S; Ponikowski P; Drożdż J; Straburzyńska-Migaj E
    Kardiol Pol; 2018; 76(7):1064-1072. PubMed ID: 29476617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Digoxin Use and Subsequent Outcomes Among Patients in a Contemporary Atrial Fibrillation Cohort.
    Allen LA; Fonarow GC; Simon DN; Thomas LE; Marzec LN; Pokorney SD; Gersh BJ; Go AS; Hylek EM; Kowey PR; Mahaffey KW; Chang P; Peterson ED; Piccini JP;
    J Am Coll Cardiol; 2015 Jun; 65(25):2691-8. PubMed ID: 26112191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Digoxin Therapy on Mortality in Patients With Atrial Fibrillation: An Updated Meta-Analysis.
    Wang X; Luo Y; Xu D; Zhao K
    Front Cardiovasc Med; 2021; 8():731135. PubMed ID: 34660731
    [No Abstract]   [Full Text] [Related]  

  • 17. Digoxin in patients with permanent atrial fibrillation: data from the RACE II study.
    Mulder BA; Van Veldhuisen DJ; Crijns HJ; Tijssen JG; Hillege HL; Alings M; Rienstra M; Van den Berg MP; Van Gelder IC;
    Heart Rhythm; 2014 Sep; 11(9):1543-50. PubMed ID: 24924587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incident frailty and cognitive impairment by heart failure status in older patients with atrial fibrillation: the SAGE-AF study.
    Wang WJ; Lessard D; Saczynski J; Goldberg RJ; Go AS; Paul T; Gracia E; McManus DD
    J Geriatr Cardiol; 2020 Nov; 17(11):653-658. PubMed ID: 33343643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-compliance with digoxin in patients with heart failure and/or atrial fibrillation: a systematic review and meta-analysis of observational studies.
    Kongkaew C; Sakunrag I; Jianmongkol P
    Arch Cardiovasc Dis; 2012 Oct; 105(10):507-16. PubMed ID: 23062482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Digoxin and clinical outcomes in the Global Rheumatic Heart Disease Registry.
    Karthikeyan G; Devasenapathy N; Zühlke L; Engel ME; Rangarajan S; Teo KK; Mayosi BM; Yusuf S;
    Heart; 2019 Mar; 105(5):363-369. PubMed ID: 30209123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.